Lesson from Lilly’s Zyprexa Settlement: Be Proactive In Monitoring Sales Reps
Executive Summary
Companies might shield themselves from claims of off-label drug marketing by adopting oversight procedures mandated in Lilly's corporate integrity agreement with HHS
You may also be interested in...
Seroquel Marketing Plan Included “Spinning The Data, aka Lilly”
Plantiffs attorneys allege that AstraZeneca internal documents reveal intense effort to imitate competitors, placate study investigators.
Lilly’s Legal Division Steers Firm Through Rough Seas Of Civil, Patent Cases
Set in a campus-like complex in downtown Indianapolis, Lilly projects a calm, unruffled atmosphere. A water fountain bubbles in front of the administrative building. Windows line the building's two-story lobby, filling the place with light. In front of the reception desk there is a display on the history of insulin, which Lilly first brought to market in 1923. And a museum with relics of the company's 133-year history stands behind it
Lilly’s Legal Division Steers Firm Through Rough Seas Of Civil, Patent Cases
Set in a campus-like complex in downtown Indianapolis, Lilly projects a calm, unruffled atmosphere. A water fountain bubbles in front of the administrative building. Windows line the building's two-story lobby, filling the place with light. In front of the reception desk there is a display on the history of insulin, which Lilly first brought to market in 1923. And a museum with relics of the company's 133-year history stands behind it